AI-DRIVEN PEPTIDE DISCOVERY
Small peptides.
Extraordinary
possibilities.
Precision starts with the right interaction. We design highly specific peptides to unlock new possibilities in therapeutics, diagnostics, and biotechnology.
Protein surface visualization
A NEW GENERATION OF MOLECULAR TOOLS
Designed to bind.
Built to make a difference.
Antibody-like recognition.
The versatility of a compact peptide.
We combine artificial intelligence, molecular modeling, and high-performance computing to create peptides that selectively recognize, bind, and modulate protein targets.
From our own research programs to custom designs for our partners, we translate complex biological challenges into precision molecular solutions.
Discover the Designed Biologics advantageONE PLATFORM. MANY POSSIBILITIES.
Precision, applied.
FROM COMPUTATION TO EXPERIMENT
Discovery backed by evidence.
PLATELET RECEPTOR · MOLECULAR SURFACE
BLOOD ADVANCES / 2026
The power to recognize
the difference.
Our G14 research demonstrates the potential to distinguish a disease-associated protein variant from its normal counterpart, opening new directions in precision therapeutics and diagnostics.
Reported binding affinity for the
disease-associated receptor variant
Experimental findings from the published study; further development and validation are needed.
MOLECULAR BIOLOGY MEETS COMPUTATIONAL SCIENCE
Built on complementary expertise.
United by possibility.
Founded by Professors Ashkan Golshani and Frank Dehne, Designed Biologics brings together peptide engineering, artificial intelligence, and large-scale computing.
Meet our co-foundersTHE NEXT DISCOVERY STARTS WITH A CONVERSATION
Have a target in mind?
Let’s turn your molecular challenge into a new possibility.